The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCELLX INC | COMMON STOCK | 03940C100 | 25,919 | 1,380,890 | SH | SOLE | 1,380,890 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 9,950 | 457,059 | SH | SOLE | 457,059 | 0 | 0 | ||
| RALLYBIO CORP | COM | 75120L100 | 10,920 | 754,678 | SH | SOLE | 754,678 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 2,394 | 99,503 | SH | SOLE | 99,503 | 0 | 0 | ||
| SEER INC | COM CL A | 81578P106 | 6,319 | 816,375 | SH | SOLE | 816,375 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 971 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 1,943 | 667,742 | SH | SOLE | 667,742 | 0 | 0 | ||
